Medical Radiology and Radiation Safety. 2022. Vol. 67. № 4

Risk Factors for Arterial Hypertension (Literature Review)

K.V. Briks

Southern Urals Biophysics Institute, Ozyorsk, Chelyabinsk region, Russia

Contact person: K.V. Briks, This email address is being protected from spambots. You need JavaScript enabled to view it.

Abstract

The review provides up-to-date data on effects of non-modifiable (sex, age) and modifiable (smoking, alcohol consumption, obesity, vitamin D deficiency, marital status, physical activity, depression) non-radiation risk factors on incidence risks of arterial hypertension. The review also refers to scientific evidence of the impact of ionizing radiation on arterial hypertension.

Keywords: arterial hypertension, ionizing radiation, risk factors, relative risk, odds ratio, excess relative risk

For citation: Briks KV. Risk Factors for Arterial Hypertension (Literature Review). Medical Radiology and Radiation Safety. 2022;67(4):24-35. DOI: 10.33266/1024-6177-2022-67-4-24-35

References

1. Chazova I.Ye., Zhernakova Yu.V. Diagnosis and Treatment of Arterial Hypertension. Guidelines. Sistemnyye gipertenzii = Systemic hypertension. 2019;16;1:6–31. doi: 10.26442/2075082X.2019.1.190179 (In Russ.).

2. NCD Risk Factor Collaboration (NCD-RisC). Worldwide Trends in Blood Pressure from 1975 to 2015: a Pooled Analysis of 1479 Population-Based Measurement Studies with 19,1 Million Participants. The Lancet. 2017;389;10064:37–55. doi: 10.1016/S0140-6736(16)31919-5.

3. Forouzanfar M.H., Liu P., Roth G.A., Ng M., Biryukov S., Marczak L., et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990–2015. Jama. 2017;317;2:165–182. doi:10.1001/jama.2016.19043.

4. Chow C.K., Teo K.K., Rangarajan S., Islam S., Gupta R., Avezum A., et al. Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries. Jama. 2013;310;9:959–968. doi:10.1001/jama.2013.184182.

5. Kearney P.M., Whelton M., Reynolds K., Whelton P.K., He J. Worldwide Prevalence of Hypertension: a Systematic Review. J. Hypertens. 2004;22;1:11–19.

6. Ettehad D., Emdin C.A., Kiran A., Anderson S.G., Callender T., Emberson J., et al. Blood Pressure Lowering for Prevention of Cardiovascular Disease and Death: a Systematic Review and Meta-Analysis. The Lancet. 2016;87;10022:957–967. doi: 10.1016/S0140-6736(15)01225-8. 

7. Lip G.Y.H., Coca A., Kahan T., Boriani G., Manolis A.S., Olsen M.H., et al. Hypertension and Cardiac Arrhythmias: Executive Summary of a Consensus Document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, Endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). European Heart Journal–Cardiovascular Pharmacotherapy. 2017;3;4:235–250. doi: 10.1093/ehjcvp/pvx019.

8. Gottesman R.F., Albert M.S., Alonso A., Coker L.H., Coresh J., Davis S.M., et al. Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort. JAMA Neurology. 2017;74;10:1246–1254. doi: 10.1001/jamaneurol.2017.1658.

9. Vishram J.K., Borglykke A., Andreasen A.H., Jeppesen J., Ibsen H., Jørgensen T., et al. Impact of Age on the Importance of Systolic and Diastolic Blood Pressures for Stroke Risk: the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project. Hypertension. 2012;60;5:1117–1123. doi: 10.1161/HYPERTENSIONAHA.112.201400.

10. Almagro P., Cabrera F.J., Diez J. Comorbidities and Shortterm Prognosis in Patients Hospitalized for Acute Exacerbation of COPD. The ESMI Study. Chest. 2012;142;5:1126–1133. doi: 10.1378/chest.11-2413.

11. Park H.J., Leem A.Y., Lee S.H., Song J.H., Park M.S., Kim Y.S., et al. Comorbidities in Obstructive Lung Disease in Korea: Data from the Fourth and Fith Korean National Health and Nutrition Examination Survey. Int. J. Chron Obstruct Pulmon Dis. 2015;10:1571–1582. doi: 10.1378/chest.11-2413.

12. Hillas G., Perlikos F., Tsiligianni I., Tzanakis N. Managing Comorbidities in COPD. Int. J. Chron Obstruct Pulmon Dis. 2015;10:95–109. doi: 10.2147/COPD.S54473.

13. Rabahi M.F., Pereira S.A., Silva Júnior J.L., de Rezende A.P., Castro da Costa A., de Sousa Corrêa K., et al. Prevalence of Chronic Obstructive Pulmonary Disease among Patients with Systemic Arterial Hypertension Without Respiratory Symptoms. Int. J. Chron Obstruct Pulmon Dis. 2015;10:1525–1529. doi: 10.2147/COPD.S85588.

14. Portegies M.L., Lahousse L., Joos G.F., Hofman A., Koudstaal P.J., Stricker B.H., et al. Chronic Obstructive Pulmonary Disease and the Risk of Stroke: the Rotterdam Study. Am. J. Respir Crit. Care Med. 2016;193;3:251–258. doi: 10.1164/rccm.201505–0962OC.

15. Gasparini A., Evans M., Coresh J., Grams M.E., Norin O., Qureshi A.R., et al. Prevalence and Recognition of Chronic Kidney Disease in Stockholm Healthcare. Nephrol. Dial. Transplant. 2016;31;12:2086-2094. doi: 10.1093/ndt/gfw354.

16. Hong J.W., Noh J.H., Kim D.J. Factors Associated with High Sodium Intake Based on Estimated 24-Hour Urinary Sodium Excretion: the 2009–2011 Korea National Health and Nutrition Examination Survey. Medicine (Baltimore). 2016;95;9:2864. doi: 10.1097/MD.0000000000002864.

17. Acuña L., Sánchez P., Soler L.A., Alvis L.F. Kidney Disease in Colombia: Priority for Risk Management. Rev. Panam. Salud Publica. 2016;40;1:16–22. PMID: 27706391.

18. Novikova D.S., Popkova T.V., Nasonov Ye.L. Arterial Hypertension in Rheumatoid Arthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2011;3:52–68 (In Russ.). 

19. Folomeyeva O.M., Nasonov Ye.L., Andrianova I.A., Galushko Ye.A., Goryachev D.V., Dubinina T.V., et al. Rheumatoid Arthritis in Rheumatological Care of Russia: The Severity of the Disease in a Russian Patient Population: a Cross-Sectional Epidemiological Study (Raiser). Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2010;1:50–60 (In Russ.).

20. Nikitina N.M., Rebrov A.P. Determining the Risk of Developing Cardiovascular Disease in Patients with Rheumatoid Arthritis. Terapevticheskiy Arkhiv = Therapeutic Archive. 2009;82;6:29–33 (In Russ.). 

21. Nasonov Ye.L., Popkova T.V. Cardiovascular Problems of Rheumatology. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2004;4:4–9 (In Russ.).

22. Gonzalez A., Maradit Kremers H., Crowson C.S., Ballman K.V., Roger V.L., Jacobsen S.J., et al. Do Cardiovascular Risk Factors Confer the Same Risk for Cardiovascular Outcomes in Rheumatoid Arthritis Patients as in Non-Rheumatoid Arthritis Patients? Ann. Rheum. Dis. 2008;67;1:64–69. doi: 10.1136/ard.2006.059980.

23. Chung C.P., Oeser A., Solus J.F., Avalos I., Gebretsadik T., Shintani A., et al. Prevalence of the Metabolic Syndrome is Increased in Rheumatoid Arthritis and is Associated with Coronary Atherosclerosis. Atherosclerosis. 2008;196;2:756–763. doi: 10.1016/j.atherosclerosis.2007.01.004.

24. Panoulas V.F., Douglas K.M., Milionis H.J., Nightingale P., Kita M.D., Klocke R., et al. Serum Uric Acid is Independently Associated with Hypertension in Patients with Rheumatoid Arthritis. J. Hum. Hypertens. 2008;22;3:177–182. doi: 10.1038/sj.jhh.1002298.

25. Del Rincón I., Freeman G.L., Haas R.W., O'Leary D.H., Escalante A. Relative Contribution of Cardiovascular Risk Factors and Rheumatoid Arthritis Clinical Manifestations to Atherosclerosis. Arthritis Rheum. 2005;52;11:3413–3423. doi: 10.1002/art.21397.

26. Dessein P.H., Joffe B.I., Stanwix A.E., Christian B.F., Veller M. Glucocorticoids and Insulin Sensitivity in Rheumatoid Arthritis. J. Rheumatol. 2004;31;5:867–874. PMID: 15124244.

27. Zhao Q., Hong D., Zhang Y., Sang Y., Yang Z., Zhang X. Association between Anti-TNF Therapy for Rheumatoid Arthritis and Hypertension: a Meta-Analysis of Randomized Controlled Trials. Medicine. 2015;94;14:e731. doi: 10.1097/MD.0000000000000731.

28. Avina-Zubieta J.A., Thomas J., Sadatsafavi M., Lehman A.J., Lacaille D. Risk of Incident Cardiovascular Events in Patients with Rheumatoid Arthritis: a Meta-Analysis of Observational Studies. Ann. Rheum Dis. 2012;71;9:1524–1529. doi: 10.1136/annrheumdis-2011-200726.

29. Choi H.K., Soriano L.C., Zhang Y., Rodríguez L.A. Antihypertensive Drugs and Risk of Incident Gout among Patients with Hypertension: Population Based Case-Control Study. BMJ. 2012;344:d8190. doi: 10.1136/bmj.d8190.

30. McAdams DeMarco M.A., Maynard J.W., Baer A.N., Gelber A.C., Young J.H., Alonso A., Coresh J. Diuretic Sue, Increased Serum Urate Levels, and Risk of Incident Gout in a Population‐Based Study of Adults with Hypertension: The Atherosclerosis Risk in Communities Cohort Study. Arthritis & Rheumatism. 2012;64;1:121–129. doi: 10.1002/art.33315.

31. Abeles A.M. Hyperuricemia, Gout, and Cardiovascular Disease: an Update. Current Rheumatology Reports. 2015;17;3:13. doi: 10.1007/s11926-015-0495-2.

32. McAdams-DeMarco M.A., Maynard J.W., Baer A.N., Coresh J. Hypertension and the Risk of Incident Gout in a Population‐Based Study: the Atherosclerosis Risk in Communities Cohort. The Journal of Clinical Hypertension. 2012;14;10:675–679. doi: 10.1111/j.1751-7176.2012.00674.x.

33. Xu W., Huang Y., Li L., Sun Z., Shen Y., Xing J., et al. Hyperuricemia Induces Hypertension Through Activation of Renal Epithelial Sodium Channel (ENaC). Metabolism. 2016;65;3:73–83. doi: 10.1016/j.metabol.2015.10.026.

34. Vaidya V., Gangan N., Sheehan J. Impact of Cardiovascular Complications among Patients with Type 2 Diabetes Mellitus: a Systematic Review. Expert Review of Pharmacoeconomics & Outcomes Research. 2015;15;3:487–497. doi: 10.1586/14737167.2015.102466.

35. De Boer I.H., Bangalore S., Benetos A., Davis A.M., Michos E.D., Muntner P., et al. Diabetes and Hypertension: a Position Statement by the American Diabetes Association. Diabetes Care. 2017;40;9:1273–1284. doi: 10.2337/dci17-0026.

36. Petrie J.R., Guzik T.J., Touyz R.M. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Canadian Journal of Cardiology. 2018;34;5:575–584. doi: 10.1016/j.cjca.2017.12.005.

37. Ntaios G., Vemmos K., Lip G.Y., Koroboki E., Manios E., Vemmou A., et al. Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source. Stroke. 2016;47;9:2278–2285. doi: 10.1161/STROKEAHA.116.013713.

38. Derakhshan A., Bagherzadeh-Khiabani F., Arshi B., Ramezankhani A., Azizi F., Hadaegh F. Different Combinations of Glucose Tolerance and Blood Pressure Status and Incident Diabetes, Hypertension, and Chronic Kidney Disease. J. Am. Heart Assoc. 2016;5;8:e003917. doi: 10.1161/JAHA.116.003917.

39. Sarwar N., Gao P., Seshasai S.R. Diabetes Mellitus, Fasting Blood Glucose Concentration, and Risk of Vascular Disease: a Collaborative Meta-Analysis of 102 Prospective Studies. Lancet. 2010;375;9733:2215–2222. doi: 10.1016/S0140-6736(10)60484-9.

40. Oshchepkova Ye.V., Lazareva N.V., Chazova I.Ye. Quality Assessment of Examination of Patients with Arterial Hypertension in Primary Health Care (According to the Russian Arterial Hypertension Register Data). Sistemnyye Gipertenzii = Systemic Hypertension. 2017;14;2:29–34. (In Russ.). doi: 10.26442/2075-082X_14.2.29-34.

41. Vera G., Nataša D., Svetlana K., Sonja S., Jasmina G., Sonja T. Epidemiology of Hypertension in Serbia: Results of a National Survey. Journal of Epidemiology. 2012;22;3:261–266. doi: 10.2188/jea.JE20110077.

42. Cutler J.A., Sorlie P.D., Wolz M., Thom T., Fields L.E., Roccella E.J. Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults between 1988–1994 and 1999–2004. J. Hypertension. 2008;52;5:818–827. doi: 10.1161/HYPERTENSIONAHA.108.113357.

43. Cheng S., Xanthakis V., Sullivan L.M., Vasan R.S. Blood Pressure Tracking over the Adult Life Course:Patterns and Correlates in the Framingham Study. Hypertension. 2012;60;6:1393–1399. doi: 10.1161/HYPERTENSIONAHA.112.201780.

44. Wright J.D., Hughes J.P., Ostchega Y., Yoon S.S., Nwankwo T. Mean Systolic and Diastolic Blood Pressure in Adults Aged 18 and over in the United States, 2001–2008. National Center Health Statistics Reports. 2011;35:24. PMID: 21485611.

45. Yoon S.S., Fryar C.D., Carroll M.D. Hypertension Prevalence and Control among Adults: United States, 2011-2014. NCHS Data Brief. 2015;220:1–8. PMID: 26633197.

46. Chow C.K., Teo K.K., Rangarajan S., Islam S., Gupta R., Avezum A., et al. Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries. Jama. 2013;310;9:959–968. doi: 10.1001/jama.2013.184182.

47. Writing Group Members, Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K., Blaha M.J., Cushman M., et al. Executive Summary: Heart Disease and Stroke Statistics – 2016 Update: A Report From the American Heart Association. Circulation. 2016;133;4:447. doi: 10.1161/CIR.0000000000000366.

48. Vishnevskiy A., Andreyev Ye., Timonin S. Mortality from Cardiovascular Diseases and Life Expectancy in Russia. Demograficheskoye Obozreniye = Demographic Review. 2016;3;1:6–34 (In Russ.).

49. Vasan R.S., Beiser A., Seshadri S., Larson M.G., Kannel W.B., D'Agostino R.B., Levy D. Residual Life Time Risk for Developing Hypeгtension in Middleaged Women and Men: The Frarningham Неагt Study. JАМА. 2002;287;8:1003–1010. doi: 10.1001/jama.287.8.1003.

50. Boytsov S.A., Balanova Yu.A., Shalnova S.A., Deyev A.D., Artamonova G.V., Gatagonova T.M., et al. Arterial Hypertension among Individuals of 25-64 Years Old: Prevalence, Awareness, Treatment and Control. By the Data from ECCD. Kardiovaskulyarnaya Terapiya i Profilaktika = Cardiovascular Therapy and Prevention 2014;14;4:4–14 (In Russ.). 

51. Ibragimova Kh.I., Mammayev S.N., Omarova D.A. Gender-Specific Regulation of Blood Pressure and Antihypertensive Treatment. Arterialnaya Gipertenziya = Arterial Hypertension. 2018;24;3:303–308 (In Russ.). doi: 10.18705/1607-419X-2018-24-3- 303-308

52. Danaei G., Finucane M.M., Lin J.K. National, Regional, and Global Trends in Systolic Blood Pressure Since 1980: Systematic Analysis of Health Examination Surveys and Epidemiological Studies with 786 Country-Years and 5,4 Million Participants. Lancet. 2011;377;9765:568–577. doi: 10.1016/S0140-6736(10)62036-3.

53. Thacker E.L., Gillett S.R., Wadley V.G., Unverzagt F.W., Judd S.E., McClure L.A., et al. The American Heart Association Life’s Simple 7 and Incident Cognitive Impairment: the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. J. Am. Heart. Assoc. 2014;3;3:e000635. doi: 10.1161/JAHA.113.000635.

54. Crim M.T., Yoon S.S., Ortiz E., Wall H.K., Schober S., Gillespie C., et al. National Surveillance Definitions for Hypertension Prevalence and Control among Adults. Circ. Cardiovasc Qual. Outcomes. 2012;5;3:343–351. doi: 10.1161/CIRCOUTCOMES.111.963439.

55. Nwankwo T., Yoon S.S., Burt V., Gu Q. Hypertension among Adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. NCHS Data Brief. 2013;133:1–8. PMID: 24171916.

56. Linneberg A., Jacobsen R.K., Skaaby T., Taylor A.E., Fluharty M.E., Jeppesen J.L., et al. Effect of Smoking on Blood Pressure and Resting Heart Rate: a Mendelian Randomization Meta-Analysis in the CARTA Consortium. Circulation: Cardiovascular Genetics. 2015;8;6:832–841. doi: 10.1161/CIRCGENETICS.115.001225.

57. Liu X., Byrd J.B. Cigarette Smoking and Subtypes of Uncontrolled Blood Pressure among Diagnosed Hypertensive Patients: Paradoxical Associations and Implications. American Journal of Hypertension. 2017;30;6:602–609. doi: 10.1093/ajh/hpx014.

58. Seven E., Husemoen L.L., Wachtell K., Ibsen H., Linneberg A., Jeppesen J.L. Five-Year Weight Changes Associate with Blood Pressure Alterations Independent of Changes in Serum Insulin. Journal of Hypertension. 2014;32;11:2231–2237. doi: 10.1097/HJH.0000000000000317.

59. Shtarik S.Yu. Connection between Alcohol Consumption and Arterial Hypertension. Byulleten Sibirskogo Otdeleniya Rossiyskoy Akademii Meditsinskikh Nauk. 2010;30;5:25–29 (In Russ.).

60. Balabina N.M., Baglushkina S.Yu. The Use of Alcohol and Arterial Pressure. Sibirskiy Meditsinskiy Zhurnal = The Siberian Medical Journal. 2012;110;3:20–22 (In Russ.).

61. Fan A.Z., Russell M., Stranges S., Dorn J., Trevisan M. Association of Lifetime Alcohol Drinking Trajectories with Cardiometabolic Risk. J. Clin. Endocrinol. Metab. 2008;93;1:154–161. doi: 10.1210/jc.2007-1395.

62. Druzhilov M.A., Druzhilova O.Yu., Beteleva Yu.Ye., Kuznetsova T.Yu. Obesity as Cardiovascular Risk Factor: Accent on Quality and Functional Activity of Adipose Tissue. Rossiyskiy Kardiologicheskiy Zhurnal = Russian Journal of Cardiology. 2015;20;4:111–117 (In Russ.). doi: 10.15829/1560-4071-2015-04-111-117.

63. Xin X., He J., Frontini M.G., Ogden L.G., Motsamai O.I., Whelton P.K. Effects of Alhohol Reduction on BP: a Meta-Analysis of Randomized Controlled Trials. Hypertension. 2001;38:1112–1117. doi: 10.1161/hy1101.093424.

64. Shalnova S.A., Konradi A.O., Balanova Yu.A., Deyev A.D., Imayeva A.E., Muromtseva G.A., et al. What Factors Do Influence Arterial Hypertension Control in Russia. Kardiovaskulyarnaya Terapiya i Profilaktika = Cardiovascular Therapy and Prevention. 2018;17;4:53–60 (In Russ.). doi: 10.15829/1728-8800-2018-4-53-60.

65. Drapkina O.M., Chaparkina S.O. Interrelation of Metabolic Syndrome, Aseptic Inflammation and Endothelial Dysfunction. Rossiyskiye Meditsinskiye Vesti. 2007;12;3:67–76 (In Russ).

66. Lee Y. Indices of Abdominal Obesity Are Better Discriminators of Cardiovascular Risk Factors Than BMi: a Meta-Analysis. Journal of Clinical Epidemiology. 2008;61:646–53. doi: 10.1016/j.jclinepi.2007.08.012.

67. Kumar S., Sharma V. Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival: the Cardiovascular Disease Lifetime Risk Pooling Project in New Delhi, India. Atherosclerosis. 2017;263:e159. doi: 10.1016/j.atherosclerosis.2017.06.504.

68. Hall J.E., do Carmo J.M., da Silva A.A., Wang Z., Hall M.E. Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms. Circulation research. 2015;116;6:991–1006. doi: 10.1161/CIRCRESAHA.116.305697.

69. Shalnova S.A., Deyev A.D., Balanova Yu.A., Kapustina A.V., Imayeva A.E., Muromtseva G.A., et al. Twenty Years Trends of Obesity and Arterial Hypertension and Their Association in Russia. Kardiovaskulyarnaya Terapiya i Profilaktika = Cardiovascular Therapy and Prevention. 2017;16;4:4–10. (In Russ.). doi: 10.15829/1728-8800-2017-4-4-10.

70. Tian S., Dong G.H., Wang D., Liu M.M., Lin Q., Meng X.J., et al. Factors Associated with Prevalence, Awareness, Treatment and Control of Hypertension in Urban Adults from 33 Communities in China: the CHPSNE Study. Hypertension Research. 2011;34;10:1087. doi:10.1038/hr.2011.99.

71. Sakboonyarat B., Mungthin M. Prevalence and Associated Factors of Uncontrolled Hypertension among Thai Patients with Hypertension: A Nationwide Cross-Sectional Survey. Rev. Epidemiol. Sante Publique. Elsevier Masson. 2018;66:S310–S311. doi: 10.1016/J.RESPE.2018.05.194.

72. Hippisley-Cox J., Coupland C., Pringle M., Crown N., Hammersley V. Married Couples’ Risk of Same Disease: Cross Sectional Study. BMJ. 2002;325;7365:636–640. doi: 10.1136/bmj.325.7365.636.

73. Di Castelnuovo A., Quacquaruccio G., Donati M.B., de Gaetano G., Iacoviello L. Spousal Concordance for Major Coronary Risk Factors: A Systematic Review and Meta-Analysis. Am. J. Epidemiol. 2009;169;1:1–8. doi: 10.1093/aje/kwn234.

74. Qi D., Nie X.L., Wu S., Cai J. Vitamin D and Hypertension: Prospective Study and Meta-Analysis. PloS One. 2017;12;3:e0174298. doi: 10.1371/journal.pone.0174298.

75. Forman J.P., Giovannucci E., Holmes M.D., Bischoff-Ferrari H.A., Tworoger S.S., Willett W.C., et al. Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension. Hypertension. 2007;49;5:1063–1069. doi: 10.1161/HYPERTENSIONAHA.107.087288.

76. Forman J.P., Curhan G.C., Taylor E.N. Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension among Young Women. Hypertension. 2008;52;5:828–832. doi: 10.1161/HYPERTENSIONAHA.108.117630.

77. Porrecca E., Di Febbo C., Fusco L., Moretta V., Di Nisio M., Cuccurullo F. Solube Thrombomodulin and Vascular Adhesion Molecule-1 Are Associated to Leptin Plasma Levels in Obese Women. Atherosclerosis. 2004;172;1:175–180. doi: 10.1016/j.atherosclerosis.2003.09.022.

78. Forouhi N.G., Luan J., Cooper A., Boucer B.J., Wareham N.J. Baseline Serum 25-Hydroxy Vitamin D is Predictive of Future Glycemic Status and Insulin Resistance: the Medical Research Council Ely Prospective Study 1990–2000. Diabetes. 2008;57;10:2619–2625. doi: 10.2337/db08–0593.

79. Meng L., Chen D., Yang Y., Zheng Y., Hui R. Depression Increases the Risk of Hypertension Incidence: a Meta-Analysis of Prospective Cohort Studies. J. Hypertens. 2012;30;5:239–243. doi: 10.1097/HJH.0b013e32835080b7.

80. Gafarov V.V., Panov D.O., Gromova Ye.A., Gagulin I.V., Gafarova A.V. Influence of Depression on Risk of Arterial Hypertension in Female 25-64 Years in Open Population. Mir Nauki, Kultury, Obrazovaniya = The World of Science, Culture and Education. 2012;4;35:277–278 (In Russ.).

81. Li Z., Li Y., Chen L., Chen P., Hu Y. Prevalence of Depression in Patients with Hypertension: a Systematic Review and Meta-Analysis. Medicine. 2015;94;31:e1317. doi: 10.1097/MD.0000000000001317.

82. Chobanov R.E., Babayeva A.D., Islamzade I.F. Assessment of the Impact of Correcting of Low Physical Activity on the Effectiveness of Treatment of Hypertension among Women of Reproductive Age in Outpatient Conditions. Vísnik Problem Biologii i Meditsiny = Bulletin of Problems in Biology and Medicine. 2016;1;4:100–104 (In Russ.). 

83. Hegde S.M., Solomon S.D. Influence of Physical Activity on Hypertension and Cardiac Structure and Function. Current Hypertension Reports. 2015;17;10:77. doi: 10.1007/s11906-015-0588-3.

84. Diaz K.M., Booth J.N., Seals S.R., Abdalla M., Dubbert P.M., Sims M., et al. Physical Activity and Incident Hypertension in African Americans: the Jackson Heart Study. Hypertension. 2017;69;3:421–427. doi: 10.1161/HYPERTENSIONAHA.116.08398.

85. Chen M., Hu J., McCoy T., Letvak S., Ivanov L. Predicting Changes in Physical Activity and Blood Pressure among Older Adults with Hypertension. Innovation in Aging. 2018;2;Suppl 1:499. doi: 10.1093/geroni/igy023.1857.

86. Börjesson M., Onerup A., Lundqvist S., Dahlöf B. Physical Activity and Exercise Lower Blood Pressure in Individuals with Hypertension: Narrative Review of 27 RCTs. Br. J. Sports Med. 2016;50;6:356–361. doi: 10.1136/bjsports-2015-095786.

87. Larsen M.K., Matchkov V.V. Hypertension and Physical Exercise: the Role of Oxidative Stress. Medicina. 2016;52;1:19–27. doi: 10.1016/j.medici.2016.01.005. 

88. Bakker E.A., Sui X., Brellenthin A.G., Lee D.C. Physical Activity and Fitness for the Prevention of Hypertension. Current Opinion in Cardiology. 2018;33;4:394–401. doi: 10.1097/HCO.0000000000000526.

89. Liu X., Zhang D., Liu Y., Sun X., Han C., Wang B., et al. Dose–Response Association between Physical Activity and Incident Hypertension: a Systematic Review and Meta-Analysis of Cohort Studies. Hypertension. 2017;69;5:813–820. doi: 10.1161/HYPERTENSIONAHA.116.08994.

90. Li W., Wang D., Wu C., Shi O., Zhou Y., Lu Z. The Effect of Body Mass Index and Physical Activity on Hypertension among Chinese Middle-Aged and Older Population. Scientific Reports. 2017;7;1:10256. doi: 10.1038/s41598-017-11037-y.

91. Vorobyev Ye.I., Stepanov R.P. Ioniziruyushcheye Izlucheniye i Krovenosnyye Sosudy = Ionizing Radiation and Blood Vessels. Moscow, Energatomizdat Publ., 1985 (In Russ.).

92. Moskalev Yu.I. Otdalennyye Posledstviya Ioniziruyushchikh Izlucheniy = Long-Term Effects of Ionizing Radiation. Moscow, Meditsina Publ., 1991 (In Russ.). 

93. Ilin L.A. Radiatsionnaya Meditsina = Radiation Medicine. Moscow, IzdAT Publ., 2001 (In Russ.). 

94. Ilin LA., Kirillov VF, Korenkov IP. Radiatsionnaya Meditsina = Radiation Medicine. Moscow, IzdAT Publ., 1999 (In Russ.).

95. Ilin L.A. Tekhnogennoye Oblucheniye i Bezopasnost Cheloveka. Elektronnyy Resurs = Technogenic Radiation and Human Safety. Electronic Resource. Moscow Publ., 2002 (In Russ.).

96. Stavitskiy R.V., Guslistyy V.P., Beridze A.D. Determination of "Small" Doses of AI by Analytical Processing of Blood Parameters. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost = Medical Radiology and Radiation Safety. 1998;43;1:58–61 (In Russ.).

97. Stavitskiy R.V., Lebedev L.A., Mekheyechev A.V., Mikheyenko S.G., Zhanina T.V. Some Items of Low Radiation Dose Effects. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost = Medical Radiology and Radiation Safety. 2003;48;1:30–39 (In Russ.).

98. Stavitskiy R.V., Lebedev L.A., Mekheyechev A.V., Zhanina T.V. Analysis of the Effects of Low-Dose Ionizing Radiation. Meditsinskaya Tekhnika = Biomedical Engineering. 2002;2:37–43 (In Russ).

99. Ryabukhin Yu.S. Low Levels of Ionizing Radiation and Health: a Systematic Approach. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost = Medical Radiology and Radiation Safety. 2000;45;4:5–42. (In Russ.).

100. Kabasheva N.Ya., Okladnikova N.D., Mamakova O.V. Causes of Lethal Outcomes and Morphologic Characteristics of Cardiovascular System in the Long-Term Period after a Chronic Exposure to Radiation. Kardiologiya = Kardiologiia. 2001;11:78. (In Russ.).

101. Tsuya A., Wakano Y., Otake M. Capillary Microscopic Observation Onthe Superficial Minute Vessels of Atomic-Bomb Survivors, 1956–57. 1. Fingernail Fold, Labial Mucosa, and Lingual Mucosa. ABCC TR 23–69. Hiroshima, Japan: Radiation Effects Research Foundation, 1969.

102. Stewart J.R., Cohn K.E., Fajardo L.F., Hancock W.E., Kaplan H.S. Radiation-Induced Heart Disease. A Study of Twenty-Five Patients. Radiology. 1967;89:302–310.

103. Van Cleave C.D. Late Somatic Effects of Ionizing Radiation. Oakridge: U.S. Atomic Energy Commission, Division of Technical Information, 1968.

104. Casarett G.W. Similarities and Contrasts between Radiation and Timepathology. Adv. Gerontol. Res. 1964;1:.109–163.

105. Reinhold H.S. Cell Viability of the Vessel Wall. Curr. Top. Radiat. Res.1974;10:9–28.

106. Little M.P., Zablotska L.B., Brenner A.V., Lipshultz S.E. Circulatory Disease Mortality in the Massachusetts Tuberculosis Fluoroscopy Cohort Study. European Journal of Epidemiology. 2015;31;3:287–309. doi: 10.1007/s10654-015-0075-9.

107. Zablotska L.B., Little M.P., Cornett R.J. Potential Increased Risk of Ischemic Heart Disease Mortality with Significant Dose Fractionation in the Canadian Fluoroscopy Cohort Study. American Journal of Epidemiology. 2013;179;1:120–131. doi: 10.1093/aje/kwt244.

108. Shimizu Y., Kodama K., Nishi N., Kasagi F., Suyama A., Soda M., et al. Radiation Exposure and Circulatory Disease Risk: Hiroshima and Nagasaki Atomic Bomb Survivor Data, 1950 – 2003. BMJ. 2010;340:b5349. doi: 10.1136/bmj.b5349.

109. Takahashi I., Shimizu Y., Grant E.J., Cologne J., Ozasa K., Kodama K. Heart Disease Mortality in the Life Span Study, 1950–2008. Radiation Research. 2017;187;3:319–332. doi: 10.1667/rr14347.1.

110. Yamada M., Lennie Wong F., Fujiwara S., Akahoshi M., Suzuki G. Noncancer Disease Incidence in Atomic Bomb Survivors, 1958–1998. Radiation Research. 2004;161;6:622–632. doi: 10.1667/rr3183.

111. Ivanov V.K., Maksioutov M.A., Chekin S.Y., Petrov A.V., Biryukov A.P., Kruglova Z.G., Kravchenko J.S. The Risk of Radiation-Induced Cerebrovascular Disease in Chernobyl Emergency Workers. Health Physics. 2006;90;3:199–207. doi: 10.1097/01.hp.0000175835.31663.ea.

112. Ivanov V.K., Chekin S.Yu., Maksyutov M.A., Kashcheyev V.V., Karpenko S.V., Tumanov K.A., et al. Radiation Risk of Incidence of Hypertensia among Russian Recovery Operation Workers of the Chernobyl Accident. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost = Medical Radiology and Radiation Safety. 2017;62;1:32–37 (In Russ.). doi: 10.12737/25050.

113. Azizova T., Briks K., Bannikova M., Grigoryeva E. Hypertension Incidence Risk in a Cohort of Russian Workers Exposed to Radiation at the Mayak Production Association Over Prolonged Periods. Hypertension. 2019;73;6:1174–1184. doi: 10.1161/HYPERTENSIONAHA.118.11719.

 PDF (RUS) Full-text article (in Russian)

Conflict of interest. The author declare no conflict of interest.

Financing. The study had no sponsorship.

Contribution. Article was prepared with equal participation of the authors

Article received: 15.03.2022.  Accepted for publication: 23.04.2022